Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease?

C. Panella, E. Ierardi, M. F. De Marco, M. Barone, F. W. Guglielmi, L. Polimeno, A. Francavilla

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Despite numerous studies on the effects of bile salts therapy in chronic liver disease, there are no reports on the influence such therapy has on hepatocyte proliferation. The aim of this preliminary study was to evaluate the effect of TUDCA on hepatocyte proliferation in 5 patients with HCV-correlated chronic liver disease. All patients were treated with TUDCA (10-13 mg/day) for three months and the determination of PCNA (Proliferating Cell Nuclear Antigen) expression was used to assess the proliferative activity of hepatocytes at the beginning and at the end of treatment. TUDCA reduced both ALT and Knodell's score in the 5 patients in whom a significant increase of PCNA-LI (p <0.05) was observed after treatment. TUDCA administration seems to stimulate hepatocyte proliferation in man.

Original languageEnglish
Pages (from-to)256-258
Number of pages3
JournalItalian Journal of Gastroenterology
Volume27
Issue number5
Publication statusPublished - 1995

Fingerprint

Liver Diseases
Hepatocytes
Chronic Disease
Proliferating Cell Nuclear Antigen
Therapeutics
Bile Acids and Salts
tauroursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Panella, C., Ierardi, E., De Marco, M. F., Barone, M., Guglielmi, F. W., Polimeno, L., & Francavilla, A. (1995). Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? Italian Journal of Gastroenterology, 27(5), 256-258.

Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? / Panella, C.; Ierardi, E.; De Marco, M. F.; Barone, M.; Guglielmi, F. W.; Polimeno, L.; Francavilla, A.

In: Italian Journal of Gastroenterology, Vol. 27, No. 5, 1995, p. 256-258.

Research output: Contribution to journalArticle

Panella, C, Ierardi, E, De Marco, MF, Barone, M, Guglielmi, FW, Polimeno, L & Francavilla, A 1995, 'Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease?', Italian Journal of Gastroenterology, vol. 27, no. 5, pp. 256-258.
Panella, C. ; Ierardi, E. ; De Marco, M. F. ; Barone, M. ; Guglielmi, F. W. ; Polimeno, L. ; Francavilla, A. / Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease?. In: Italian Journal of Gastroenterology. 1995 ; Vol. 27, No. 5. pp. 256-258.
@article{e4b423861746468cb75a6afde8245296,
title = "Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease?",
abstract = "Despite numerous studies on the effects of bile salts therapy in chronic liver disease, there are no reports on the influence such therapy has on hepatocyte proliferation. The aim of this preliminary study was to evaluate the effect of TUDCA on hepatocyte proliferation in 5 patients with HCV-correlated chronic liver disease. All patients were treated with TUDCA (10-13 mg/day) for three months and the determination of PCNA (Proliferating Cell Nuclear Antigen) expression was used to assess the proliferative activity of hepatocytes at the beginning and at the end of treatment. TUDCA reduced both ALT and Knodell's score in the 5 patients in whom a significant increase of PCNA-LI (p <0.05) was observed after treatment. TUDCA administration seems to stimulate hepatocyte proliferation in man.",
author = "C. Panella and E. Ierardi and {De Marco}, {M. F.} and M. Barone and Guglielmi, {F. W.} and L. Polimeno and A. Francavilla",
year = "1995",
language = "English",
volume = "27",
pages = "256--258",
journal = "Italian Journal of Gastroenterology",
issn = "0392-0623",
publisher = "Piccin Editore",
number = "5",

}

TY - JOUR

T1 - Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease?

AU - Panella, C.

AU - Ierardi, E.

AU - De Marco, M. F.

AU - Barone, M.

AU - Guglielmi, F. W.

AU - Polimeno, L.

AU - Francavilla, A.

PY - 1995

Y1 - 1995

N2 - Despite numerous studies on the effects of bile salts therapy in chronic liver disease, there are no reports on the influence such therapy has on hepatocyte proliferation. The aim of this preliminary study was to evaluate the effect of TUDCA on hepatocyte proliferation in 5 patients with HCV-correlated chronic liver disease. All patients were treated with TUDCA (10-13 mg/day) for three months and the determination of PCNA (Proliferating Cell Nuclear Antigen) expression was used to assess the proliferative activity of hepatocytes at the beginning and at the end of treatment. TUDCA reduced both ALT and Knodell's score in the 5 patients in whom a significant increase of PCNA-LI (p <0.05) was observed after treatment. TUDCA administration seems to stimulate hepatocyte proliferation in man.

AB - Despite numerous studies on the effects of bile salts therapy in chronic liver disease, there are no reports on the influence such therapy has on hepatocyte proliferation. The aim of this preliminary study was to evaluate the effect of TUDCA on hepatocyte proliferation in 5 patients with HCV-correlated chronic liver disease. All patients were treated with TUDCA (10-13 mg/day) for three months and the determination of PCNA (Proliferating Cell Nuclear Antigen) expression was used to assess the proliferative activity of hepatocytes at the beginning and at the end of treatment. TUDCA reduced both ALT and Knodell's score in the 5 patients in whom a significant increase of PCNA-LI (p <0.05) was observed after treatment. TUDCA administration seems to stimulate hepatocyte proliferation in man.

UR - http://www.scopus.com/inward/record.url?scp=0028807362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028807362&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 256

EP - 258

JO - Italian Journal of Gastroenterology

JF - Italian Journal of Gastroenterology

SN - 0392-0623

IS - 5

ER -